证券记录 · 已归档季度
RCUS
Arcus Biosciences, Inc. · Healthcare · Biotechnology
15被追踪持有人
-1Δ持有人
35.18M持有股份
$286.34M报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -6.2% ·
股份流向 +9.5% ·
净新建仓位 -6.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | +1 | 62.00M | $1.91B | +8 | −7 |
| Q1 2026 | 85 | -2 | 57.45M | $1.24B | +6 | −8 |
| Q4 2025 | 87 | -1 | 64.26M | $1.53B | +1 | −2 |
| Q3 2025 | 20 | +2 | 36.84M | $500.99M | +2 | — |
| Q2 2025 | 15 | -1 | 35.18M | $286.34M | — | −1 |
| Q1 2025 | 13 | +2 | 11.54M | $90.60M | +4 | −2 |
| Q4 2024 | 11 | 0 | 8.18M | $121.86M | +1 | −1 |
| Q3 2024 | 10 | 0 | 4.70M | $71.80M | — | — |
| Q2 2024 | 10 | — | 4.00M | $60.94M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 11.46M | — | $93.27M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (被动) | 6.56M | — | $53.37M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (被动) | 6.56M | — | $53.37M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (被动) | 6.56M | — | $53.37M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (被动) | 6.56M | — | $53.37M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (被动) | 6.56M | — | $53.37M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 5.97M | +108.1% | $48.57M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (被动) | 3.63M | -1.8% | $29.55M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Fidelity (FMR) ✦ | 2.57M | — | $20.95M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 2.57M | — | $20.95M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 2.57M | — | $20.95M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 2.57M | — | $20.95M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Geode Capital Management ✦ (被动) | 1.60M | +14.9% | $12.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (被动) | 1.60M | +14.9% | $12.99M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 936.02K | -13.6% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | Wellington Management ✦ | 936.02K | -13.6% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Wellington Management ✦ | 936.02K | -13.6% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 32 | Wellington Management ✦ | 936.02K | -13.6% | $7.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 33 | Millennium Management ✦ | 780.09K | -34.7% | $6.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 34 | Citadel Advisors ✦ | 611.20K | +62.1% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Citadel Advisors ✦ | 611.20K | +62.1% | $4.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Two Sigma Investments ✦ | 408.19K | +36.8% | $3.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Renaissance Technologies ✦ | 368.10K | +80.4% | $3.00M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 108.30K | +19.1% | $881,555 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 108.30K | +19.1% | $881,555 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 108.30K | +19.1% | $881,555 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 108.30K | +19.1% | $881,555 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | Fisher Asset Management ✦ | 88.16K | -36.0% | $717,646 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 43 | D. E. Shaw & Co. ✦ | 51.32K | -8.4% | $417,777 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 44.37K | +30.2% | $362,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Marshall Wace | $879,601 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 209 持有人, 119.00M 股份, $2.56B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 21
Azoy Alexander
Officer · 2.83K 股 · $84,810
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 07
SC 13D/A — GILEAD SCIENCES, INC.
24.7% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据